Thomas A. Puchalski
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 6
- Peptidase Inhibition and Analysis 6
- Immunology top 5%
- Hematology top 2%
- Multiple Myeloma Research and Treatments 14
- Cancer Research top 5%
-
- Monoclonal and Polyclonal Antibodies Research 12
-
- Chronic Lymphocytic Leukemia Research 9
-
- Angiogenesis and VEGF in Cancer 7
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- Shobha SeetharamJohann S. de BonoDavid P. RyanRocio García‐CarboneroJeffrey G. SupkoBirge BernsRobert G. MakiDavid C. Harmon
- Cited by
- OncologyImmunologyHematology
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Thomas A. Puchalski
50 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 1.5k
- Immunology 789
- Hematology 362
- Cancer Research 413
- Pulmonary and Respiratory Medicine 834
Countries citing papers authored by Thomas A. Puchalski
This map shows the geographic impact of Thomas A. Puchalski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Puchalski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Puchalski more than expected).
Fields of papers citing papers by Thomas A. Puchalski
This network shows the impact of papers produced by Thomas A. Puchalski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Puchalski. The network helps show where Thomas A. Puchalski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas A. Puchalski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 0 | |
| 2 | 2016 | 63 | |
| 3 | 2015 | 10 | |
| 4 | 2013 | 166 | |
| 5 | 2013 | 26 | |
| 6 | 2013 | 228 | |
| 7 | 2013 | 11 | |
| 8 | 2013 | 3 | |
| 9 | 2012 | 54 | |
| 10 | 2011 | 93 | |
| 11 | 2010 | 86 | |
| 12 | 2010 | 47 | |
| 13 | 2009 | 42 | |
| 14 | 2007 | 57 | |
| 15 | 2005 | 3 | |
| 16 | 2004 | 250 | |
| 17 | 2004 | 29 | |
| 18 | 2003 | 21 | |
| 19 | 2002 | 55 | |
| 20 | 2001 | 23 |
About Thomas A. Puchalski
Thomas A. Puchalski is a scholar working on Hematology, Oncology and Genetics, having authored 51 papers that have together received 2.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Chronic Lymphocytic Leukemia Research (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Angiogenesis and VEGF in Cancer (7 papers), Cancer Treatment and Pharmacology (6 papers), Peptidase Inhibition and Analysis (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (789 citations) and Hematology (362 citations). Thomas A. Puchalski has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Shobha Seetharam, Johann S. de Bono, David P. Ryan, Rocio García‐Carbonero, Jeffrey G. Supko, Birge Berns, Robert G. Maki, David C. Harmon, José Jimeno and George D. Demetri. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.